SMTL ID : 1dfh.1

X-RAY STRUCTURE OF ESCHERICHIA COLI ENOYL REDUCTASE WITH BOUND NAD AND THIENO-DIAZABORINE

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.20 Å

Oligo State

homo-tetramer

Ligands

4 x NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE(Non-covalent)

NAD.1: 24 residues within 4Å: Chain A: G.12, V.13, A.14, S.18, I.19, Q.39, L.43, C.62, D.63, V.64, S.90, I.91, G.92, I.118, L.143, S.144, Y.145, K.162, A.188, G.189, P.190, I.191, F.202 Ligands: TDB.2 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:I.19, A:Y.145, A:A.188 Hydrogen bonds: A:G.12, A:S.18, A:I.19, A:D.63, A:V.64, A:I.91, A:G.92, A:K.162, A:I.191 NAD.3: 23 residues within 4Å: Chain B: G.12, V.13, A.14, S.18, I.19, Q.39, L.43, C.62, D.63, V.64, S.90, I.91, G.92, I.118, L.143, S.144, Y.145, K.162, A.188, G.189, P.190, I.191 Ligands: TDB.4 13 PLIP interactions: 13 interactions with chain B Hydrophobic interactions: B:I.19, B:Y.145, B:A.188 Hydrogen bonds: B:G.12, B:S.18, B:I.19, B:Q.39, B:D.63, B:V.64, B:I.91, B:G.92, B:K.162, B:I.191 NAD.5: 24 residues within 4Å: Chain C: G.12, V.13, A.14, S.18, I.19, Q.39, L.43, C.62, D.63, V.64, S.90, I.91, G.92, I.118, L.143, S.144, Y.145, K.162, A.188, G.189, P.190, I.191, F.202 Ligands: TDB.6 13 PLIP interactions: 13 interactions with chain C Hydrophobic interactions: C:I.19, C:Y.145, C:A.188 Hydrogen bonds: C:G.12, C:S.18, C:I.19, C:Q.39, C:D.63, C:V.64, C:I.91, C:G.92, C:K.162, C:I.191 NAD.7: 23 residues within 4Å: Chain D: G.12, V.13, A.14, S.18, I.19, Q.39, L.43, C.62, D.63, V.64, S.90, I.91, G.92, I.118, L.143, S.144, Y.145, K.162, A.188, G.189, P.190, I.191 Ligands: TDB.8 13 PLIP interactions: 13 interactions with chain D Hydrophobic interactions: D:I.19, D:Y.145, D:A.188 Hydrogen bonds: D:G.12, D:S.18, D:I.19, D:Q.39, D:D.63, D:V.64, D:I.91, D:G.92, D:K.162, D:I.191

4 x TDB: 6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL(Non-covalent)

TDB.2: 9 residues within 4Å: Chain A: G.92, F.93, Y.145, Y.155, M.158, K.162, I.199, F.202 Ligands: NAD.1 6 PLIP interactions: 6 interactions with chain A Hydrophobic interactions: A:Y.145, A:Y.155, A:I.199, A:F.202 Hydrogen bonds: A:Y.155, A:K.162 TDB.4: 9 residues within 4Å: Chain B: G.92, F.93, Y.145, Y.155, M.158, K.162, I.199, F.202 Ligands: NAD.3 5 PLIP interactions: 5 interactions with chain B Hydrophobic interactions: B:Y.145, B:Y.155, B:I.199, B:F.202 Hydrogen bonds: B:K.162 TDB.6: 9 residues within 4Å: Chain C: G.92, F.93, Y.145, Y.155, M.158, K.162, I.199, F.202 Ligands: NAD.5 5 PLIP interactions: 5 interactions with chain C Hydrophobic interactions: C:Y.145, C:Y.155, C:I.199, C:F.202 Hydrogen bonds: C:K.162 TDB.8: 9 residues within 4Å: Chain D: G.92, F.93, Y.145, Y.155, M.158, K.162, I.199, F.202 Ligands: NAD.7 6 PLIP interactions: 6 interactions with chain D Hydrophobic interactions: D:Y.145, D:Y.155, D:I.199, D:F.202 Hydrogen bonds: D:Y.155, D:K.162

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Baldock, C. et al., A mechanism of drug action revealed by structural studies of enoyl reductase. Science (1996)

Release Date

1998-01-28

Peptides

ENOYL ACYL CARRIER PROTEIN REDUCTASE: ABCD

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
A

D
B

ENOYL ACYL CARRIER PROTEIN REDUCTASE

Related Entries With Identical Sequence